F
Test Bank Pharmacology: A Patient-Centered
TLL
F TLL
F TLL
F TLL
F
F TLL Nursing Process Approach 11th Edition ISBN:
F TLL TLL
F TLL
F F TLL F TLL
9780323793155 Jennifer Yeager, Kathleen
F T L L F TLL F TLL F TLL
F DiMaggio, Linda McCuistion, Mary Winton
TLL TLL
F TLL
F TLL
F TLL
F
, Test Bank Pharmacology: A Patient-Centered Nursing Process Approach 11th Edition ISBN:
F TLL F TLL F TLL TLL
F F TLL TLL
F TLL
F F TLL F TLL F TLL
9780323793155 Jennifer Yeager, Kathleen DiMaggio, Linda McCuistion, Mary Winton
F TLL F TLL F TLL F TLL F TLL F TLL F TLL F TLL F TLL
Table of Content TLL
F F TLL
1. Clinical Judgment Management Model (CJMM) and the Nursing Process
TLL
F F TLL TLL
F F TLL TLL
F TLL
F TLL
F F TLL TLL
F
2. Drug Development and Ethical Considerations
TLL
F TLL
F F TLL TLL
F TLL
F
3. Pharmacokinetics and Pharmacodynamics
F TLL F TLL F TLL
4. Pharmacogenetics
F TLL
5. Complementary and Alternative Therapies
TLL
F TLL
F FTLL FTLL
6. Pediatric Considerations
F TLL F TLL
7. Drug Therapy in Older Adults
F TLL F TLL TLL
F F TLL TLL
F
8. Drugs in Substance Use Disorder
TLL
F TLL
F F TLL F TLL F TLL
9. Safety and Quality
F TLL TLL
F F TLL
10. Drug Administration
F TLL F TLL
11. Drug Calculations
F TLL F TLL
12. Fluid Volume and Electrolytes
TLL
F F TLL F TLL F TLL
13. Vitamin and Mineral Replacement
TLL
F F TLL FTLL TLL
F
14. Nutritional Support
TLL
F F TLL
15. Adrenergic Agonists and Antagonists
TLL
F F TLL TLL
F TLL
F
16. Cholinergic Agonists and Antagonists
TLL
F F TLL TLL
F F TLL
17. Stimulants
F TLL
18. Depressants
F TLL
19. Antiseizure Drugs
TLL
F FTLL
20. Drugs for Parkinsonism and Alzheimer Disease
TLL
F F TLL F TLL F TLL F TLL TLL
F
21. Drugs for Neuromuscular Disorders and Muscle Spasms
TLL
F F TLL F TLL F TLL F TLL TLL
F F TLL
22. Antipsychotics and Anxiolytics
TLL
F TLL
F F TLL
23. Antidepressants and Mood Stabilizers
TLL
F TLL
F F TLL TLL
F
24. Antiinflammatories
F TLL
25. Analgesics
F TLL
26. Penicillins, Other Beta-Lactams, and Cephalosporins
TLL
F F TLL F TLL F TLL TLL
F
27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides
TLL
F FTLL TLL
F TLL
F TLL
F TLL
F TLL
F
28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
TLL
F F TLL F TLL TLL
F TLL
F
29. Sulfonamides and Nitroimidazoles Antibiotics
TLL
F F TLL F TLL TLL
F
30. Antituberculars, Antifungals, and Antivirals
TLL
F TLL
F TLL
F F TLL
31. Antimalarials, Anthelmintics, and Peptides
TLL
F TLL
F TLL
F TLL
F
32. HIV- and AIDS-Related Drugs
TLL
F F TLL F TLL F TLL
33. Transplant Drugs
TLL
F F TLL
34. Vaccines
F TLL
35. Anticancer Drugs
TLL
F F TLL
36. Targeted Therapies to Treat Cancer
TLL
F F TLL TLL
F F TLL F TLL
37. Biologic Response Modifiers
TLL
F TLL
F TLL
F
38. Upper Respiratory Disorders
TLL
F F TLL F TLL
,39. Lower Respiratory Disorders
F TLL F TLL F TLL
40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
TLL
F TLL
F F TLL TLL
F F TLL
41. Diuretics
F TLL
42. Antihypertensives
F TLL
43. Anticoagulants, Antiplatelets, and Thrombolytics
TLL
F TLL
F F TLL TLL
F
44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow
TLL
F TLL
F F TLL TLL
F TLL
F TLL
F F TLL F TLL
45. Gastrointestinal Tract Disorders
TLL
F F TLL F TLL
46. Antiulcer Drugs
TLL
F F TLL
47. Eye and Ear Disorders
F TLL F TLL F TLL F TLL
48. Dermatologic Disorders
TLL
F F TLL
49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
TLL
F F TLL TLL
F TLL
F F TLL TLL
F
50. Antidiabetics
F TLL
51. Urinary Disorders
TLL
F F TLL
52. Pregnancy and Preterm Labor
TLL
F F TLL TLL
F F TLL
53. Labor, Delivery, and Postpartum
F TLL TLL
F F TLL TLL
F
54. Neonatal and Newborn
TLL
F F TLL F TLL
55. Women’s Reproductive Health
TLL
F TLL
F TLL
F
56. Men’s Reproductive Health
TLL
F F TLL TLL
F
57. Sexually Transmitted Infections
TLL
F TLL
F TLL
F
58. Adult and Pediatric Emergency Drugs
TLL
F TLL
F F TLL F TLL F TLL
, Chapter 01: The Nursing Process and Patient-Centered Care
TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F
McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
MULTIPLE CHOICE TLL
F
1. All of the following would be considered subjective data, EXCEPT:
TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F F TLL F TLL TLL
F
a. Patient-reported health history TLL
F TLL
F
b. Patient-reported signs and symptoms of their illness TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
c. Financial barriers reported by the patient’s caregiver TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
d. Vital signs obtained from the medical record TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
ANS: D F T LL
Subjective data is based on what patients or family members communicate to the nurse. TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F F TLL F TLL TLL
F TLL
F
FPatient-reported health history, signs and symptoms, and caregiver reported financial
TLL TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
Fbarriers would be considered subjective data. Vital signs obtained from the medical
TLL F TLL TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F TLL
F F TLL TLL
F
Frecord would be considered objective data.
TLL F TLL TLL
F TLL
F F TLL TLL
F
DIF: Cognitive Level: Understanding (Comprehension) TLL
F TLL
F TLL
F TOP: Nursing Process: F T LL TLL
F
Planning MSC: NCLEX: Management of Client Care
TLL
F TLL
F F T L L TLL
F F TLL TLL
F F TLL
2. The nurse is using data collected to define a set of interventions to achieve the most
TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F
TLL
F desirable outcomes. Which of the following steps is the nurse applying? TLL
F F TLL TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F
a. Recognizing cues (assessment) TLL
F TLL
F
b. Analyze cues & prioritize hypothesis (analysis) TLL
F TLL
F TLL
F TLL
F TLL
F
c. Generate solutions (planning) TLL
F TLL
F
d. Take action (nursing interventions) TLL
F TLL
F TLL
F
ANS: C F T LL
When generating solutions (planning), the nurse identifies expected outcomes and uses
F TLL TLL
F TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F
Fthe patient’s problem(s) to define a set of interventions to achieve the most desirable
TLL TLL
F F TLL TLL
F F TLL F TLL TLL
F F TLL TLL
F TLL
F F TLL TLL
F TLL
F TLL
F
Foutcomes. Recognizing cues (assessment) involves the gathering of cues (information)
TLL TLL
F TLL
F TLL
F TLL
F TLL
F FTLL TLL
F TLL
F TLL
F
Ffrom the patient about their health and lifestyle practices, which are important facts
TLL TLL
F TLL
F TLL
F F TLL TLL
F TLL
F FTLL TLL
F TLL
F TLL
F TLL
F TLL
F
Fthat aid the nurse in making clinical care decisions. Prioritizing hypothesis is used to
TLL TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F
organize and rank the patient problem(s) identified. Finally, taking action involves
TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F TLL
F
implementation of nursing interventions to accomplish the expected outcomes.
TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F TLL
F
DIF: Cognitive Level: Understanding TLL
F F TLL
F(Comprehension) TOP: Nursing Process: Nursing
TLL TLL
F F T L L TLL
F TLL
F
Intervention
TLL
F
MSC: NCLEX: Management of Client Care F T L L F TLL TLL
F TLL
F TLL
F
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for
TLL
F F TLL TLL
F F TLL TLL
F TLL
F TLL
F FTLL F TLL TLL
F TLL
F F TLL
Fepisodes of hyperglycemia. The parents tell the nurse that they can’t keep track of
TLL TLL
F F TLL F TLL TLL
F F TLL TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F TLL
F F TLL
Feverything that has to be done to care for their child. The nurse reviews medications,
TLL TLL
F F TLL F TLL F TLL F TLL F TLL TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F
Fdiet, and symptom management with the parents and draws up a daily checklist for the
TLL F TLL TLL
F TLL
F TLL
F TLL
F TLL
F F TLL TLL
F TLL
F TLL
F F TLL TLL
F FTLL TLL
F
Ffamily to use. These activities are completed in which step of the nursing process?
TLL TLL
F TLL
F TLL
F F TLL TLL
F F TLL TLL
F TLL
F F TLL TLL
F TLL
F TLL
F TLL
F
a. Recognizing cues (assessment) TLL
F TLL
F
b. Analyze cues & prioritize hypothesis (analysis) TLL
F TLL
F TLL
F TLL
F TLL
F